Updated on 12 December 2013
The acquisition will also provide access to highly skilled staff to support both manufacturing requirements and new product development. The staff who have been retained are trained in operating clean room facilities as well as experienced in producing medical products for human treatments.
"This acquisition represents an important step forward for Admedus as it gives us immediate access to a fully functional facility, the necessary equipment and trained, experienced staff. As a result this will accelerate our ability to increase the manufacturing of CardioCel as market demand grows," said Mr Rodne.